Stockscreener 앱 받기
8.25
5.63%
0.44
전일 마감가:
$7.81
열려 있는:
$8.24
하루 거래량:
136.92K
Relative Volume:
1.36
시가총액:
$142.38M
수익:
-
순이익/손실:
$-33.82M
주가수익비율:
-0.3224
EPS:
-25.5891
순현금흐름:
$-66.04M
1주 성능:
+2.36%
1개월 성능:
+1.23%
6개월 성능:
-8.84%
1년 성능:
+28.11%
1일 변동 폭
$7.82
$9.00
1주일 범위
$7.48
$9.00
52주 변동 폭
$4.60
$12.62
Elicio Therapeutics Inc Stock (ELTX) Company Profile
명칭
Elicio Therapeutics Inc
전화
(857) 209-0050
주소
451 D STREET, 5TH FLOOR, BOSTON
ELTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
8.25 | 134.79M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Elicio Therapeutics Inc 주식(ELTX)의 최신 뉴스
Responsive Playbooks and the ELTX Inflection - Stock Traders Daily
Aug Volume: Will Elicio Therapeutics Inc benefit from AI trendsJuly 2025 Macro Moves & Weekly Setup with High ROI Potential - baoquankhu1.vn
Profit Review: What are the future prospects of Elicio Therapeutics Inc2025 Key Highlights & Fast Entry High Yield Tips - baoquankhu1.vn
Elicio Therapeutics reports inducement grants - TipRanks
Biotech Elicio offers 22,400 stock options to attract new hires - Stock Titan
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why - Eastern Progress
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? - Eastern Progress
Why Elicio Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Catalysts & Safe Entry Trade Signal Reports - Улправда
Why CBLL stock attracts strong analyst attention - Улправда
How rising interest rates impact Elicio Therapeutics Inc. stock2025 Technical Overview & Reliable Volume Spike Trade Alerts - Улправда
Why Elicio Therapeutics Inc. stock is seen as undervaluedJuly 2025 Setups & Technical Pattern Alert System - Улправда
How Elicio Therapeutics Inc. stock reacts to Fed rate cutsREITs Market Trends & Free High Margin Investment Plays - Улправда
Understanding the Setup: (ELTX) and Scalable Risk - Stock Traders Daily
How (ELTX) Movements Inform Risk Allocation Models - Stock Traders Daily
What is the fair value of Elicio Therapeutics Inc. stock nowJuly 2025 Drop Watch & Technical Entry and Exit Alerts - Улправда
Dividend Watch: Can Elicio Therapeutics Inc. stock hit record highs again2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Улправда
Aug Decliners: Why Elicio Therapeutics Inc stock could rally in 2025July 2025 Setups & Verified Chart Pattern Signals - moha.gov.vn
Will Elicio Therapeutics Inc. stock benefit from green energy trendsWeekly Investment Summary & Reliable Entry Point Alerts - Улправда
Is Elicio Therapeutics Inc. stock ready for breakoutJuly 2025 Gainers & Entry Point Confirmation Alerts - bolumsonucanavari.com
FOMO Trade: Can Elicio Therapeutics Inc. stock hit record highs again2025 Geopolitical Influence & Entry and Exit Point Strategies - Улправда
How supply chain issues affect Elicio Therapeutics Inc. stockMarket Movers & Reliable Breakout Forecasts - DonanımHaber
Why Elicio Therapeutics Inc. stock could rally in 2025Earnings Risk Summary & Weekly High Potential Alerts - Улправда
Can Elicio Therapeutics Inc. stock withstand economic slowdownLong Setup & AI Forecasted Entry and Exit Points - Улправда
Elicio Therapeutics Earnings Notes - Trefis
Elicio Therapeutics Reports Inducement Grants - The Manila Times
Elicio Therapeutics (Nasdaq: ELTX) issues 157K options at $8.52 - Stock Titan
Understanding Momentum Shifts in (ELTX) - Stock Traders Daily
Elicio Therapeutics (ELTX) upgraded to buy: Here's why - MSN
Elicio’s cancer vaccine triggers broad anti-tumor immunity - Rare Cancer News
Elicio reports antigen spreading in 87% of evaluated cancer patients - Investing.com
Elicio reports antigen spreading in 87% of evaluated cancer patients By Investing.com - Investing.com Australia
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial - Yahoo Finance
Pancreatic Ductal Adenocarcinoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Elicio Therapeutics, Cend Therapeutics, Silenseed, Amplia - Barchart.com
How Elicio Therapeutics Inc. (9HA) stock reacts to stronger dollarQuarterly Market Summary & Safe Capital Allocation Plans - Newser
How Elicio Therapeutics Inc. (9HA) stock reacts to new regulations2025 Winners & Losers & Long-Term Growth Plans - Newser
Will Elicio Therapeutics Inc. (9HA) stock benefit from mergersTrade Ideas & Risk Controlled Swing Trade Alerts - Newser
Avoiding Lag: Real-Time Signals in (ELTX) Movement - Stock Traders Daily
Can Elicio Therapeutics Inc. stock deliver surprise earnings beat2025 Volatility Report & Real-Time Buy Zone Alerts - Newser
Can Elicio Therapeutics Inc. (9HA) stock sustain margin levelsAnalyst Downgrade & Safe Capital Growth Plans - Newser
Will Elicio Therapeutics Inc. stock benefit from AI adoptionWeekly Stock Recap & Weekly Stock Performance Updates - Newser
How Elicio Therapeutics Inc. (9HA) stock trades in high volatilityWeekly Trade Recap & Weekly Return Optimization Alerts - Newser
Is Elicio Therapeutics Inc. (9HA) stock undervalued historicallyTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Will Elicio Therapeutics Inc. (9HA) stock split increase liquidity2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
Elicio Therapeutics Inc (ELTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):